Cipla partners with Sanofi India

27 Mar 2024 Evaluate

Cipla has entered into exclusive partnership with Sanofi India (SIL) and Sanofi Healthcare India (together referred as Sanofi India) for distribution and promotion of Sanofi India’s Central Nervous System (CNS) product range in India. As a part of this partnership, Cipla will be responsible for the distribution of Sanofi India’s six CNS brands including Frisium, a leading brand in the anti-epileptic medication category. 

While Sanofi India will continue to own, import, and manufacture its complete range of CNS products across plants in India and internationally, Cipla will leverage its capabilities and robust India-wide network of strong marketing and sales professionals, distributors, institutions, and market outreach programs to expand access to these treatments for patients who need them.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. 


Cipla Share Price

1399.20 -10.20 (-0.72%)
29-Apr-2024 11:18 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1521.80
Dr. Reddys Lab 6266.50
Cipla 1399.20
Zydus Lifesciences 962.15
Lupin 1633.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.